Millennium Pharmaceuticals, Inc. (MLNM)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
3044	135	0	MLNM

Emcee: icanpickem	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1594	Jeez. The entire issue is on proteosome inhibition. ---	microcapfun	-	6/3/2003
1593	Hatching a DNA Giant It used to take years to find a single gene. Now Millennium	Icebrg	-	6/3/2003
1592	<b>from G-S Morning Research Report today:</b> We continue to view	PCSS	-	6/3/2003
1591	The Molecular Prospective: Ubiquitin and the Proteosome. For a relatively basic	Icebrg	-	6/3/2003
1590	Here's the whole MLNM ASCO presentation... ©2003 Millennium Pharmaceut	Ian@SI	-	6/2/2003
1589	MLNM just finished its ASCO presentation. Slides are available at its web site	Ian@SI	-	6/2/2003
1588	Millennium Announces Preliminary Phase I and Phase II Findings of VELCADE(TM) (B	Ian@SI	-	6/2/2003
1587	ASCO server is down???	Miljenko Zuanic	-	6/1/2003
1586	Link doesn't work for me. Cheers! (eom)	scaram(o)uche	-	6/1/2003
1585	asco.org	Miljenko Zuanic	-	6/1/2003
1584	Thanks M Novartis are well ahead of MLNM, who hasn't even started phase II	Icebrg	-	6/1/2003
1583	*2265 Oral PKC 412 has activity in patients (pts) with mutant FLT3 acute myeloid	Miljenko Zuanic	-	6/1/2003
1582	Millennium says cancer drug safe over longer term Sunday June 1, 5:59 pm ET L	SemiBull	-	6/1/2003
1581	Ugh. Biotech investors don't want that. Imagine if GA and epoD play out.	scaram(o)uche	-	6/1/2003
1580	So MLNM needs to buy KOSN and kick their cancer program into high gear.	jayhawk969	-	6/1/2003
1579	Speaking of combing Velcade with other regimens . . . From AACR, now r	tuck	-	6/1/2003
1578	Picked up on Yahoo: Cancer Treat Rev 2003 May;29 Suppl 1:41-8 Clinical update:	IRWIN JAMES FRANKEL	-	5/31/2003
1577	MLNM gained 9.05% this week. Many quality biotech stocks have continued their up	blackmerlin	-	5/31/2003
1576	I wrote: >> Conclusion: This appears to be an interesting approach. The f	Icebrg	-	5/30/2003
1575	MLN518 There were a couple of posts over at Yahoo that raised my interest in th	Icebrg	-	5/30/2003
1574	Velcade in Relapsing-Refractory Multiple Myeloma: A Newsmaker Interview With Pau	SemiBull	-	5/29/2003
1573	Cancer Drugs: At Last, a Tonic for Biotech Tests results for Genentech's A	SemiBull	-	5/29/2003
1572	I don't know if specific solid tumor types were discussed, so here are a cou	tuck	-	5/27/2003
1571	If you listen to the last conference call, the details were given with much more	Ian@SI	-	5/26/2003
1570	<i> The sales potential for Velcade in multiple myeloma approximates $200-	microcapfun	-	5/24/2003

Go to reply# or date (mm/dd/yy):